← Back to Search

My Diabetes Care for Diabetes

N/A

Waitlist Available

Led By William Martinez, MD, MS

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Type 2 Diabetes Mellitus

Age 18-75 years old

Must not have

Receiving dialysis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (t0), three-month follow-up (t1), six-month follow-up (t2), twelve-month follow-up (t3)

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if the My Diabetes Care portal can help improve clinical outcomes for patients with diabetes.

Who is the study for?

This trial is for adults aged 18-75 with Type 2 Diabetes who are on medication, can use a smartphone or computer with internet, and have an active patient web portal account at VUMC or BWH. They must be able to understand English or Spanish. Those on dialysis, pregnant, or in long-term care cannot join.

What is being tested?

The study tests 'My Diabetes Care', a patient portal intervention designed to improve diabetes management through technology. Participants will be randomly assigned to two groups: one using the MDC system and the other continuing usual care.

What are the potential side effects?

Since this trial involves a digital patient management tool rather than medication, traditional side effects are not expected. However, participants may experience issues related to usability of the app such as frustration or difficulty navigating the interface.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have Type 2 Diabetes.

Select...

I am between 18 and 75 years old.

Select...

I am currently on medication for diabetes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am currently on dialysis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (t0), three-month follow-up (t1), six-month follow-up (t2), twelve-month follow-up (t3)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (t0), three-month follow-up (t1), six-month follow-up (t2), twelve-month follow-up (t3)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (t0), three-month follow-up (t1), six-month follow-up (t2), twelve-month follow-up (t3) for reporting.